This Dividend King's Yield Hasn't Been This High in a Decade. Is It a Buy?

Abbott Laboratories is highlighted as offering an approaching 3% dividend yield while still growing its business, with its Dividend King status underscoring durability. The piece notes the stock is not a deep bargain and that rising costs remain a headwind, but the income-growth combination is presented as attractive for dividend-focused investors.

Analysis

Abbott Laboratories is highlighted as offering an approaching 3% dividend yield while still growing its business, with its Dividend King status underscoring durability. The piece notes the stock is not a deep bargain and that rising costs remain a headwind, but the income-growth combination is presented as attractive for dividend-focused investors.